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Angela HaczkuAbstract
The pulmonary innate immune system is heavily implicated in the perpetual airway inflammation and impaired
host defense characterizing Chronic Obstructive Pulmonary Disease (COPD). The airways of patients suffering from
COPD are infiltrated by various immune and inflammatory cells including macrophages, neutrophils, T lymphocytes,
and dendritic cells. While the role of macrophages, neutrophils and T lymphocytes is well characterized, the
contribution of dendritic cells to COPD pathogenesis is still the subject of emerging research. A paper by Botelho
and colleagues in the current issue of Respiratory Research investigates the importance of dendritic cell recruitment
in cigarette-smoke induced acute and chronic inflammation in mice. Dendritic cells of the healthy lung
parenchyma and airways perform an important sentinel function and regulate immune homeostasis. During
inflammatory responses the function and migration pattern of these cells is dramatically altered but the underlying
mechanisms are incompletely understood. Botelho and colleagues demonstrate here the importance of
IL-1R1/IL-1α related mechanisms including CCL20 production in cigarette-smoke induced recruitment of dendritic
cells and T cell activation in the mouse lung.
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The average lungs filter through approximately 11,000 L
air a day with numerous potentially toxic, infectious or
allergenic particles landing on a football-field size re-
spiratory surface area. Yet, the healthy respiratory muco-
sal surface is maintained in a pathogen and inflammation
free state. The innate immune system has a constitutive
daunting task of eliminating inhaled particles, educating
the adaptive immune system (T cells and B cells) and
preventing inappropriate inflammatory changes. This
entails a tightly regulated cooperation between structural
cells (fibroblasts, smooth muscles and epithelial cells), al-
veolar macrophages and dendritic cells. The latter nor-
mally reside in the lung parenchyma and airways,
sampling the environment and regulating immune
homeostasis in the proximal and distal air spaces. Acute
inflammatory responses elicit an intricately organized
hierarchy and trafficking of subpopulations of this highly
heterogeneous cell type. The importance of these
changes in COPD has been raised by a number ofCorrespondence: haczku@mail.med.upenn.edu
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reproduction in any medium, provided the orlaboratories [1-6]. Many questions are however remain
unanswered. For example, what are the danger signals
and downstream pathways that induce dendritic cell
changes in COPD? How do dendritic cell subpopulations
differentiate and what is their significance in the chronic-
ally inflamed airways? What chemokine receptor-ligand
pairs regulate accumulation of dendritic cells in the lung/
airways? Is there a role for antigen presentation and the
adaptive immune response in COPD? In the current
issue of Respiratory Research Botelho and colleagues
bring us closer to understanding some of these questions
by assessing cigarette-smoke induced accumulation of
dendritic cells in the lung in a relevant murine model [7].Danger signals for dendritic cell maturation and
migration during the inflammatory airway response in
COPD
Dendritic cells are professional antigen-presenting cells
and regulators of immunity and tolerance. Under baseline
conditions, these cells reside in the peripheral tissue in an
immature, resting state scattered throughout the respira-
tory mucosal wall. They are capable of capturing patho-
gens but unable to present them to T cells in this state. Inhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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receptors or proinflammatory cytokines, dendritic cells
start to mature and switch from “antigen capturing” to
“antigen presenting” and T-cell–stimulatory mode. To
study the role of different danger signals in dendritic cell
migration and activation during cigarette-smoke induced
inflammatory responses, in the present paper Botelho and
colleagues [7] investigated IL-1R1, TLR4 and IL-1α defi-
cient mice as well as anti IL-1α and IL-1β blocking anti-
bodies. Their results showed that accumulation and
activation of dendritic cells were IL-1R1/IL-1α dependent
but TLR4 and IL-1β independent. While both IL-1α [8]
and IL-1β [9] are found significantly increased in COPD,
the data presented here suggest that IL-1α specific path-
ways are important and that activation of inflammasome
related events may not be required for dendritic cell mat-
uration/migration. Given however that the NLRP3 and
the TLR4/myD88 pathways are thought to be essential in
cigarette smoke induced pulmonary inflammation in mice
[10] it would be important to clarify whether these path-
ways are indeed redundant in regulating dendritic cell mi-
gration in COPD.
Significance of dendritic cell subclasses
Dendritic cells originate from the monocyte and den-
dritic cell progenitor. Committed dendritic progenitors
in the bone marrow give rise to pre-dendritic cells,
which migrate from the bone marrow to lymphoid and
non-lymphoid tissues where their maturation and differ-
entiation is regulated by different cytokines and growth
factors. Phenotypically different populations of conven-
tional dendritic cells have been identified in the respira-
tory mucosal tissue. It is important to differentiate
between dendritic cell subsets because they play very dif-
ferent roles such as inducing tolerance versus driving
the immune response. According to cell surface marker
profile, in the lung for example, the majority of the resi-
dent dendritic cells under baseline conditions are made
up by the plasmocytoid type (120G8high/PDCA-1high/
Gr1high/B220high) shown to be tolerogenic in allergen-
induced inflammation. On the other hand, myeloid den-
dritic cells (CD11chigh/CD11bhigh/MHC-IIhigh) migrate
rapidly to the lung during inflammation. The integrin
CD103 (alpha(E)) was shown to denote a population of
dendritic cells in skin, lung, and intestine that can effi-
ciently present exogenous antigens in their correspond-
ing draining lymph nodes to specific CD8+ T cells
through cross-presentation. CD103+ dendritic cells also
contribute to the control of inflammatory responses and
mucosal homeostasis by fostering the conversion of
naive T cells into induced Foxp3+ regulatory T cells,
mediated by transforming growth factor-beta and retin-
oic acid signaling. Unfortunately, to date there is an al-
most complete absence of knowledge on how dendriticcell subsets are regulated in COPD. Although the paper
by Bothelo et al. did not study any particular subclasses
they demonstrated their findings on relevant CD11chigh/
MHC-IIhigh/CD86high cells that belong to the highly ma-
ture dendritic cell population with antigen presenting
and CD4+ T cell stimulatory capabilities.Role of chemokines in dendritic cell accumulation in the
lung in COPD
In addition to differential maturation, distinct patterns
of tissue and lymph node directed migration determine
dendritic cell function and the outcome of inflammatory
response. Dendritic cells and other members of the in-
nate and adaptive immune system migrate to peripheral
and lymphoid tissues during inflammation and utilize
over 40 chemokines and 20 chemokine receptors in this
process [11,12]. Cigarette smoke was recently shown to
induce activation of the CCL19-CCR7, CXCL1-CXCR2,
CCL2-CCR2/4 and CCL20-CCR6 pathways, pertinent to
dendritic cell migration in mice [3,13-15] and COPD
patients [6]. Previous work [15] showed that lack of
CCR6 in gene deficient mice inhibited dendritic cell ac-
cumulation and airway inflammation in cigarette smoke
exposed mice, highlighting the importance of the
CCL20-CCR6 ligand-receptor pair. Botelho et al. used
an elegant bone marrow reconstitution experiment that
resulted in CCL20 and GM-CSF production in response
to cigarette smoke in wild type but not IL-1R1−/− re-
cipient mice. This suggested the importance of IL-1R1
expression on structural cells in production of CCL20
and the ensuing dendritic cell accumulation in the
cigarette smoke exposed lung.Is there a role for antigen presentation in COPD?
Although all mature dendritic cells share a common
ability to process and present antigen to naive T cells for
the initiation of an immune response, they are highly
heterogeneous in origin, migratory patterns, localization,
cytokine/mediator production and cell-surface marker
expression. This heterogeneity in turn is important in
determining the outcome of the immune response (i.e.
tolerance vs. activation). In murine models of COPD
dendritic cells were suggested to play a role by activation
of autoreactive T cells and induce emphysema in mice in
an IL-17A dependent fashion [16]. Although the paper
by Botelho et al. did not investigate whether antigen
presentation was involved, they showed diminished acti-
vation of CD4 and CD8 T cells in the IL-1R1−/− (but
not the TLR4−/−) mice. This is actually not surprising
given that T cells require IL-1 for activation. The role of
dendritic cells in this effect will therefore need further
investigation.
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Bothelo and colleagues demonstrated here that acute
and chronic cigarette smoke exposure induces dendritic
cell migration into the lung in an IL-1R1 dependent
manner. They show the importance of IL-1α as opposed
to IL-1β or TLR4 in this process, and imply an IL-1R1
driven CCL20 pathway. They also show that T cell acti-
vation is diminished in the absence of IL-1R1 and IL-1
α. This study highlights the role of dendritic cells in the
pathogenesis of COPD and contributes to the founda-
tion on which the underlying regulatory mechanisms
maybe unraveled.
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